Search research articles
Contact Us
Filters
Showing results (211-220 of 215) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 215 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
K Suzuki, T Yamanaka, H Hashimoto, et al.
ESMO Open
|
July 17, 2022
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer
K Hotta, T Hida, H Nokihara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2023
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
A Passaro, J Wang, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
E Felip, B C Cho, V Gutiérrez, et al.
Clinical EEG and Neuroscience
|
December 26, 2013
Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013
B J He, G Nolte, K Nagata, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 215) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 215 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
K Suzuki, T Yamanaka, H Hashimoto, et al.
ESMO Open
|
July 17, 2022
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer
K Hotta, T Hida, H Nokihara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2023
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
A Passaro, J Wang, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
E Felip, B C Cho, V Gutiérrez, et al.
Clinical EEG and Neuroscience
|
December 26, 2013
Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013
B J He, G Nolte, K Nagata, et al.
Page
of 22